Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet ...Middle East

PR Newswire - News
STOCKHOLM, Aug. 15, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced publication in The Lancet of the full data from the Phase 3 NefIgArd Study with Nefecon® (TARPEYO® (budesonide) delayed release capsules/Kinpeygo®)...

Hence then, the article about calliditas therapeutics announces full results from the nefigard phase 3 trial published in the lancet was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News